Arexis AB
Records under this name other than the patents Arexis AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,852,608 | Antibodies Against and Methods for Producing Vaccines for Respiratory Syncytial Virus Lapsed on the fee record Ended Oct 7, 2026 · High confidence | Lapsed on the fee record | Ended Oct 7, 2026 | High confidence |
| US 9,096,658 | Antibodies Against and Methods for Producing Vaccines for Respiratory Syncytial Virus Term ended Term ended Sep 9, 2026 · High confidence | Term ended | Term ended Sep 9, 2026 | High confidence |
| US 9,913,894 | Antibodies Against and Methods for Producing Vaccines for Respiratory Syncytial Virus Term ended Term ended Sep 21, 2025 · High confidence | Term ended | Term ended Sep 21, 2025 | High confidence |
| US 7,872,052 | Use of Heterocyclic Compounds as Scce Inhibitors Term ended Term ended Mar 4, 2025 · High confidence | Term ended | Term ended Mar 4, 2025 | High confidence |
| US 7,132,100 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Term ended Jun 13, 2023 · High confidence | Term ended | Term ended Jun 13, 2023 | High confidence |
| US 7,294,336 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Term ended Jun 13, 2023 · High confidence | Term ended | Term ended Jun 13, 2023 | High confidence |
| US 7,785,592 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Term ended Jun 13, 2023 · High confidence | Term ended | Term ended Jun 13, 2023 | High confidence |
| US 8,007,793 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Ended no later than Jun 13, 2023 · Medium confidence | Term ended | Ended no later than Jun 13, 2023 | Medium confidence |
| US 8,206,951 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Term ended Jun 13, 2023 · High confidence | Term ended | Term ended Jun 13, 2023 | High confidence |
| US 8,460,663 | Stabilized Liquid Anti-Rsv Antibody Formulations Term ended Term ended Jun 13, 2023 · High confidence | Term ended | Term ended Jun 13, 2023 | High confidence |